SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from BIO KEY INTERNATIONAL INC (BKYI) (CIK 0001019034) (BKYI) — Dec 31, 2013

BIO KEY INTERNATIONAL INC (BKYI) (CIK 0001019034)
Date: Dec. 31, 2013 · CIK: 0001019034 · Accession: 0001437749-13-016581

Offering / Registration Process Regulatory Compliance Financial Reporting

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-190200, 333-192504

Date
December 31, 2013
Author
Assistant Director
Form
CORRESP
Company
BIO KEY INTERNATIONAL INC (BKYI) (CIK 0001019034)

Letter

VIA EDGAR Division of Corporation Finance Washington, DC 20549 Re: BIO-Key International, Inc.- Registration Statement on Form S-1 Commission File No. 333-192504

Dear Ms. Jacobs:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, BIO-Key International, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-190200) (the “Registration Statement”), so that it may become effective at 4:30 p.m. on December 31, 2013, or as soon thereafter as practicable.

The Registrant hereby acknowledges that:

(i)

should the Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the Registration Statement;

(ii)

the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and

(iii)

the Registrant may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Thank you for your prompt attention to this request. We request that such effectiveness be confirmed in writing.

Very truly yours,
BIO-KEY INTERNATIONAL, INC.

Show Raw Text
CORRESP
1
filename1.htm

bkyi20131231_corresp.htm

BIO-KEY INTERNATIONAL, INC.

3349 Highway 138, Building D, Suite B

Wall, New Jersey 07719

December 31, 2013

VIA EDGAR

Barbara C. Jacobs

Assistant Director

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F. Street, NE

Washington, DC 20549

Re:

BIO-Key International, Inc.- Registration Statement on Form S-1

Commission File No. 333-192504

Dear Ms. Jacobs:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, BIO-Key International, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-190200) (the “Registration Statement”), so that it may become effective at 4:30 p.m. on December 31, 2013, or as soon thereafter as practicable.

The Registrant hereby acknowledges that:

(i)

should the Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the Registration Statement;

(ii)

the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and

(iii)

the Registrant may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Thank you for your prompt attention to this request. We request that such effectiveness be confirmed in writing.

Very truly yours,

BIO-KEY INTERNATIONAL, INC.

By: /s/ Michael W. DePasquale

Michael W. DePasquale

Chief Executive Officer